Crowdonomics
This isn’t Intec Bioplastics, Inc.’s most recent raise. Reg A+ · Equity · Feb 2026 (Open) is more current.View latest round
Intec Bioplastics, Inc.

Reg CF · Common Stock · Jul 2024

ClosedReg CFCommon Equity
via ANDES CAPITAL GROUP, LLC · last checked Aug 17, 2026
Raised
$0
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$2.3M
FY2022
$0
−$7.4M
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$2,345,130
-$7,438,869
Taxes paid
$0
$0
Balance sheet
Cash
$21,690
$38,494
Accounts receivable
$0
$0
Total assets
$21,690
$38,494
Short-term debt
$2,467,060
$9,922,733
Long-term debt
$0
$0
Total liabilities
$2,467,060
$9,922,733
Other
Headcount
—
12

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Aug 28, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Aug 27, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Aug 1, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Price / share$1.00
Shares offered10,000

Offering details

Target$10,000
Max—
Min investment—
OpenedJul 18, 2024
DeadlineDec 31, 2024
ClosedDec 31, 2024
Days active166

Links & provenance

Source: SEC EDGAR
0001096906-24-001543
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.